Category: Research

Recently published research shows that CAR-T cell therapy, a type of immunotherapy, has the ability to treat diffuse midline glioma

Recent research has demonstrated that combination therapy to target a specific protein, called MYC, in tumour cells could prove to be effective in treating medulloblastoma

A recent study discovered that a protein, called FOXM1, is responsible for clinically aggressive meningiomas

Recent research has uncovered a metabolic pathway that could be involved in tumour survival and growth

Research funded by The Brain Tumour Charity has led to the development of a classification system for brain tumours based on molecular profiling

Last week we convened a panel of internationally renowned experts in the field, for our ‘Ask the Researcher: Panel Edition’ event at Kings College London

Results from a phase 1 clinical trial, testing a drug called CLR 124, demonstrates its ability to cross the blood-brain barrier

Researchers design immune cells to target a protein found on two thirds of glioblastomas, the most common and lethal primary brain tumour

A European research collaboration is developing a new “laboratory on a chip” device that will be able to rapidly detect the different types of cancer stem cells involved in two of the most aggressive brain tumours

New research shows that an immunotherapy called CAR-T cell therapy—currently only effective in treating blood cancer—has the potential to treat solid tumours, such as brain tumours

A phase 2 clinical trial testing an immunotherapy drug called ipilimumab to treat patients with glioblastomas has been announced in the United Kingdom

On 6 March, we’re hosting a unique opportunity to get your research questions answered as our Scientific Advisory Board comes together from across the globe

Results of two phase 2 clinical trials testing cabozantinib suggest that anti-angiogenic therapy could be used to treat glioblastomas

Researchers at Massachusetts General Hospital prepare to launch a phase 1 clinical trial to test the combination therapy of hydroxyurea and temozolomide (TMZ)

Our Research Engagement Manager Becky Birch, outlines developments highlighted by Tessa Jowell’s debate

In her interview on the Today programme, Tessa Jowell talked about adaptive clinical trials. Find out more

A study involving multiple institutions in the United States reported that conventional cancer therapy initiates a series of events that encourage living cancer cells to grow and develop new tumours

Researchers have discovered that the circadian rhythm, also known as a person’s ‘internal clock’, could hold the answers to develop new therapies for glioblastoma

Scotland-based charity, Worldwide Cancer Research, has formed a unique partnership with us to fund two outstanding scientists’ work on brain cancer

Research funded by The Brain Tumour Charity has proved for the first time that a naturally-occurring virus can cross the blood-brain barrier in humans and attack tumour cells in the brain

Patients with glioblastoma are wearing a cap that delivers electronic fields to treat their brain tumours

Our Head of Research, Phil Hexley, outlines what happened at SNO: the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology

Researchers at UC San Francisco develop a vaccine to treat diffuse midline glioma by using the patient’s immune system to attack the tumour cells

Our Head of Research, Phil Hexley, outlines what happened at SNO: the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology